Suppr超能文献

晶体液简史:争议的起源

A brief history of crystalloids: the origin of the controversy.

作者信息

Fernández-Sarmiento Jaime, Casas-Certain Carolina, Ferro-Jackaman Sarah, Solano-Vargas Fabian H, Domínguez-Rojas Jesús Ángel, Pilar-Orive Francisco Javier

机构信息

Department of Critical Care Medicine and Pediatrics, Universidad de La Sabana, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.

Department of Pediatrics, Universidad del Rosario, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.

出版信息

Front Pediatr. 2023 Jul 3;11:1202805. doi: 10.3389/fped.2023.1202805. eCollection 2023.

Abstract

Fluid resuscitation with crystalloids has been used in humans for more than 100 years. In patients with trauma, sepsis or shock of any etiology, they can help modify the clinical course of the illness. However, these solutions are medications which are not side-effect free. Recently, they have been questioned in terms of quantity (fluid overload) and their composition. The most frequently used crystalloids, both in high and low-income countries, are 0.9% normal saline (NS) and Ringer's lactate. The first descriptions of the use of sodium and water solutions in humans date from the cholera epidemic which spread throughout Europe in 1831. The composition of the fluids used by medical pioneers at that time differs greatly from the 0.9% NS used routinely today. The term " referred to fluids which did not cause red blood cell hemolysis in amphibians in studies years later. 0.9% NS has an acid pH, a more than 40% higher chloride concentration than plasma and a strong ion difference of zero, leading many researchers to consider it an unbalanced solution. In many observational studies and clinical trials, this 0.9% NS composition has been associated with multiple microcirculation and immune response complications, acute kidney injury, and worse clinical outcomes. Ringer's lactate has less sodium than plasma, as well as other electrolytes which can cause problems in patients with traumatic brain injury. This review provides a brief summary of the most important historical aspects of the origin of the most frequently used intravenous crystalloids today.

摘要

晶体液复苏在人类中已使用了100多年。在创伤、脓毒症或任何病因引起的休克患者中,它们有助于改变疾病的临床进程。然而,这些溶液是药物,并非没有副作用。最近,它们在用量(液体超负荷)及其成分方面受到了质疑。在高收入和低收入国家,最常用的晶体液是0.9%的生理盐水(NS)和乳酸林格氏液。人类使用钠和水溶液的最早描述可追溯到1831年席卷欧洲的霍乱疫情。当时医学先驱们使用的液体成分与如今常规使用的0.9%生理盐水有很大不同。多年后的研究中,“”一词指的是不会导致两栖动物红细胞溶血的液体。0.9%的生理盐水呈酸性pH值,氯化物浓度比血浆高40%以上,强离子差为零,这使得许多研究人员认为它是一种不平衡的溶液。在许多观察性研究和临床试验中,这种0.9%生理盐水的成分与多种微循环和免疫反应并发症、急性肾损伤以及更差的临床结果有关。乳酸林格氏液的钠含量低于血浆,以及其他可能给创伤性脑损伤患者带来问题的电解质。本综述简要总结了当今最常用静脉晶体液起源的最重要历史方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8956/10351043/5b26b6bd6d14/fped-11-1202805-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验